Praxis Precision Medicines (PRAX) Interest & Investment Income (2019 - 2026)
Praxis Precision Medicines' (PRAX) quarterly Interest & Investment Income came in at -$2.2 million in Q1 2026, down 43240.0% year-on-year from N/an in Q1 2025, and down 717.05% quarter-over-quarter from -$264000.0 in Q2 2025.
Praxis Precision Medicines (PRAX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Interest & Investment Income history runs 8 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 43240.0% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$1.0 million, a 175.9% decrease from a year earlier, with the FY2022 full-year figure at $957000.0, up 253.14% from the prior year.
- Interest & Investment Income slipped to -$2.2 million in Q1 2026 per PRAX's latest filing, from -$264000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.4 million in Q3 2024 and bottomed at -$2.2 million in Q1 2026.
- The 5-year median for Interest & Investment Income is $4000.0 (2024), against an average of $3750.0.
- Across the five-year window, Interest & Investment Income soared 135.81% in 2023 and tumbled 43240.0% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $1.3 million in 2022, then tumbled by 98.56% to $19000.0 in 2023, then soared by 7278.95% to $1.4 million in 2024, then slumped by 118.83% to -$264000.0 in 2025, then slumped by 717.05% to -$2.2 million in 2026.
- Per Business Quant, the three latest PRAX Interest & Investment Income figures stand at -$2.2 million (Q1 2026), -$264000.0 (Q2 2025), and $5000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Praxis Precision Medicines | 9.20 Bn | 8.42 Bn | - | -2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.16 Mn |
| Jun 30, 2025 | -264,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | -74,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 154,000.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 144,000.00 |
| Jun 30, 2022 | -74,000.00 |
| Mar 31, 2022 | -430,000.00 |
| Jun 30, 2021 | 36,000.00 |
| Mar 31, 2021 | -86,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 128,000.00 |
| Dec 31, 2019 | 22,000.00 |
| Sep 30, 2019 | 48,000.00 |